tiprankstipranks
Trending News
More News >
Livzon Pharmaceutical Group Inc Class H (HK:1513)
:1513
Hong Kong Market

Livzon Pharmaceutical Group (1513) Income Statement

Compare
0 Followers

Livzon Pharmaceutical Group Income Statement

Last quarter (Q1 2025), Livzon Pharmaceutical Group's total revenue was ¥3.18B, a decrease of -1.92% from the same quarter last year. In Q1, Livzon Pharmaceutical Group's net income was ¥636.71M. See Livzon Pharmaceutical Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 11.81B¥ 12.43B¥ 12.63B¥ 12.06B¥ 10.52B
Gross Profit
¥ 7.73B¥ 7.66B¥ 8.17B¥ 7.81B¥ 6.85B
Operating Expenses
¥ 4.89B¥ 5.24B¥ 5.93B¥ 5.62B¥ 4.53B
Depreciation and Amortization
¥ 575.14M¥ 840.32M¥ 652.32M¥ 445.27M¥ 394.30M
EBITDA
¥ 3.47B¥ 3.33B¥ 3.08B¥ 2.77B¥ 2.91B
Operating Income
¥ 2.84B¥ 2.42B¥ 2.35B¥ 2.27B¥ 2.50B
Other Income/Expenses
¥ -38.25M¥ -32.44M¥ -20.01M¥ -21.30M¥ -11.01M
Pretax Income
¥ 2.81B¥ 2.38B¥ 2.33B¥ 2.25B¥ 2.49B
Net Income
¥ 2.06B¥ 1.95B¥ 1.91B¥ 1.78B¥ 1.71B
Per Share Metrics
Basic EPS
¥ 2.24¥ 2.10¥ 2.04¥ 1.90¥ 1.83
Diluted EPS
¥ 2.24¥ 2.10¥ 2.04¥ 1.90¥ 1.83
Weighted Average Shares Outstanding
920.13M 930.31M 933.86M 934.46M 936.16M
Weighted Average Shares Outstanding (Diluted)
920.13M 930.61M 935.98M 934.57M 937.11M
Currency in CNY

Livzon Pharmaceutical Group Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis